Across TCGA pan-cancer cohorts, MIR518A1 RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated MIR518A1 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher MIR518A1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR518A1 expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

STAD, CESC, and ESCA are the cancer types where MIR518A1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	III,IV	0.167	0.532	.002	90	view →
CESC	OS	Tertile	All	0.523	0.877	<.001	72	view →
ESCA	OS	Tertile	III,IV	0.823	0.357	.023	18	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: MIR518A1 tumor-vs-normal RNA expression · all MIR518A1 data types